
|Articles|February 5, 2007
Democrats reopen debate on Medicare Part D
The Democrats opened a new salvo in the battle over the Medicare drug benefit with the introduction of the Medicare Prescription Drug Price Negotiation Act of 2007. The bill, which passed the House mostly along party lines, mandates that the Secretary of the Department of Health & Human Services (DHHS) negotiate directly with drug companies over drug prices charged to prescription drug plans (PDPs). Still, the bill's future and how it will impact pharmacy remains unclear.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
REM-Dominant Sleep Apnea Significantly More Prominent Following COVID-19
2
Pharmacists Empower Patients to Improve Insulin Management
3
Most Favored Nation: Global Benchmarking to Reimagine US Drug Distribution
4
Expert Addresses Pharmacy’s Uncertainty Amid MFN Drug Pricing Policy
5






















































































































